Alka Batycky's most recent trade in Landos Biopharma Inc was a trade of 3,600 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 30, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Landos Biopharma Inc | Alka Batycky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2023 | 3,600 | 3,600 | - | - | Stock Option (right to buy) |